Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GetRch, interesting that you’re lecturing on patience now. The posts relating to future PRs by Pragmatic and I are clear statements of how the PMA timeline works. And could (should in my opinion) result in a PR.
BTW, where was your patience in March when you wrote:
“8 weeks to review sterilization data and submit is plenty long enough to have given a further update. This tells me that either they submitted and have big news coming, but are fearful of leaks so don't want another PR, or they are clueless on what to do next and are fumbling around looking for a Doug-like expert to bail them out.
Enough is enough Brian - Finish the Deal!”
OR Dec 2023:
“11 weeks is MORE THAN ENOUGH TIME to complete those tests. From the companies I've run, and my experience, If I was Thom, I would be sleeping at the test facility, right next to the testing team and the owners working daily to get this done well, ASAP.
I get "wait and see for shareholders." The wait and see by Thom while the test facility F#*^S around is INEXCUSABLE. Take some ownership and walk the test facility across the finish line.”
Can you name a single time ueec has shared negative news or verified one of their failed PMA attempts? My question goes back for a time period of over a decade. Thanks, in advance, for your response.
No reason for Brian to share any news until the FDA makes an announcement is correct!
$5-$10+
"we doubt that shareholders will hear about it. We expect it will be just like when UEEC applied for PMA approval for Class III in late 2017, there will just not be any updates, like it never happened."
https://seekingalpha.com/article/4300303-united-health-products-press-releases-cannot-be-taken-face-value
As I've stated before. UEEC has zero reason to update shareholders or issue a PR until there is something to actually write about. They are not going to spend money having a PR written that states "Still waiting on the FDA." We must be patient. Patient that the process is executing as it should. That UEEC is providing answers to any questions the FDA may have. That the FDA is following their process, doing site visits as needed, etc.
There is zero benefit for Brian or anyone else at this company to hide information, or slow play this. It's very clear, the eggs are all in one basket . . . getting FDA approval.
Let's all have a bit more patience, and fingers crossed for some good news as soon as the news is actually news and not just rumors or speculation.
It’s amazing how bad you are at this, considering you post so often.
You are a living contrast to the book “Outliers.”
Malcolm will have to do a complete rewrite of his premise.
BTW were you drunk when you wrote this:
That’s pretty sad Zorax. Did you spend the last 3 weeks reviewing my posts (as I suggested) looking for any evidence of a “GRAFT?”
I know that’s an impossible task.
I wanted you to spend the time learning about hemostyp and the PMA process. Not looking for “grafts.”
When I reply to Shoone, and provide clarity that may support his view, then so be it.
I’m not on anyone’s side here. I just provide realistic, fact based information.
I believe I also had to help him when he made a “graft” about Texas and Nevada.
Your tax comment is full of “grafts” as well.
It actually exposes just how desperate you are.
You completely misinterpreted my statement with your “tax friendly “ gibberish.
I didn’t say Nevada was a Tax Free state. I clearly said Zero Taxable Gains.
I also said “hope to go tax free”. Hope. No guarantees.
BTW were you drunk when you wrote this:
“Thanks for that. I'm disappointed that your superior intellect didn't catch your graft. Or as an employee of uhp, just setting up the groundwork for a furture p&d?”
👍️SEC👍️ Charges Rhode Island Stock Promoter with Microcap Fraud
https://www.sec.gov/litigation/litreleases/lr-25993
The companies in question are SOLY, CNSP, EBET, VLCN, TOBAF
The Securities and Exchange Commission today announced charges against Cranston, Rhode Island resident Ahmed Alomari and MCM Consulting, the entity Alomari controls, for fraud and other securities law violations related to their promotion of the stocks of at least five microcap issuers.
The SEC alleges that from at least March 2019 and continuing to February 2022, Alomari used such outlets as Twitter, Instagram, Facebook, investor chatrooms, and text blasts to promote these microcap stocks without disclosing the source or amount of compensation he received from, or on behalf of, the issuers for his promotion of their stocks. The SEC further alleges that Alomari personally invested in some of these issuers' securities, then surreptitiously sold the stocks while publicly recommending that investors buy them. This conduct included two initial public offerings in which Alomari allegedly invested and quickly sold all his shares for at least $1.4 million in profits. According to the SEC's complaint, Alomari also was able to publicly sell shares he had earned from his promotional services based on false representation letters confirming that the shares were available for public trading. The SEC alleges that Alomari directed his wife, whom he named as the sole officer of MCM Consulting, to sign the false representation letters.
The SEC's complaint, filed in the U.S. District Court for the District of Rhode Island, charges Alomari and MCM Consulting with violating the anti-fraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, the anti-touting provisions of Section 17(b) of the Securities Act, which prohibit promotion of a security without disclosure of compensation received for the promotional activity, and the registration provisions of Section 5(a) and (c) of the Securities Act. The SEC's complaint additionally charges Alomari with violating Section 20(b) of the Exchange Act by violating the anti-fraud provisions through or by means of his wife. The complaint seeks, as to both Alomari and MCM Consulting, permanent injunctions from violating the charged provisions of the federal securities laws, disgorgement, prejudgment interest, civil monetary penalties, and a penny stock bar. The complaint also seeks a bar against Alomari from acting as an officer or director of a public company.
The SEC's case is being handled by Richard Harper, Jeffrey Cook, Alexandra Lavin, Jonathan Menitove, Ryan Murphy, and Celia Moore of the SEC's Boston Regional Office.
Interesting. Then you readily admit that there is indeed a company/employer connection between the states and shoon is actually correct in his contentions? Because that was his point after all.
Thanks for that. I'm disappointed that your superior intellect didn't catch your graft. Or as an employee of uhp, just setting up the groundwork for a furture p&d?
By the way, Nevada is tax and filing inc friendly, not tax free.
Their original office was in Nevada.
Former CEO and majority shareholder continues to live in Nevada. Hence, they may as well keep a PO Box and hope to go tax free after the big acquisition.
Pragmatic, I think we here the FDA has accepted the PMA and my feeling is that because of the 3rd party RCA the file is completed fully and we begin the who knows how long wait for approval. JMO
Pragmatic, another accurate post re the current state of the PMA and where it stands with the FDA. Thank You, Hopefully UHP updates Shareholders in a timely manner.
If/when they announce if the FDA has agreed to File the application, Hemostyp will then (and only then) move on to the full review stage.
Typically UHP is quick with positive news, and vague with negative news. We’ll see what happens this time around.
Here’s a quote from the last time Hemostyp got to this stage successfully.
May 5,2021,— yes 3 years ago.
“following the resubmission of its application for Pre-market Approval for HemoStyp gauze on April 6th, the FDA has now accepted for review and commenced its Substantive Review of the application.”
Hopefully there are no resubmissions required this time around. As in that case, the original was submitted Oct 2020.
Shoon, does Halo ring a bell??? Talk about SCUMBAGFRAUDSTERS
Shoondale, is there any stocks that you actually like?
SEEMS you spout the same thing about every stock you follow?
Bit bizarre.
ANYONE have any insight on shoony?
"we doubt that shareholders will hear about it. We expect it will be just like when UEEC applied for PMA approval for Class III in late 2017, there will just not be any updates, like it never happened."
https://seekingalpha.com/article/4300303-united-health-products-press-releases-cannot-be-taken-face-value
Yesterday marked 6 weeks from when UEEC reported that the application was submitted. The FDA has 45 days to review the application, so UEEC should hear something from the FDA by Tuesday at the latest.
UEEC--Heading into another great and GREEN week
Market makers have control of this until we get news and the correct volume comes in.. MM’s are just ping ponging it
Couldn’t agree with you more
If we are looking at a 24 week FDA window; we are about 20% thru that evaluation period.
The investment (or gamble) is in the final stretch for a decision. Hard to see any logic for those
selling; I hold to the end. Got to ride this one out.
UEEC--Heading into another great and GREEN week.
TIC TOC
Broker running a stock scam is very beneficial..https://brokercheck.finra.org/individual/summary/4231884
Good volume too !!
Banjo50, this fraudulent scam isn't worth more than...$0.0001...https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf
How is this company still alive. Nothing has changed on progression in 6 years. Sti saying the same thing
I think it should be five cents. Five cents is a fair price. I will buy at five cents.
Another Green Day ??
Cool……
$$ UEEC $$
CHARLIESAN
Re: rodman post# 12756
Tuesday, December 19, 2023 12:11:04 PM
Post# 12757 of 13460
"Yes, I am a loser; about 800K in this position; and I own a significant amount of shares; in the 7 digits. You must be braindead to think that this CEO and management team do not deserve criticism in their inability to get a PMA filed. They need prodded; pushed; criticized; by any means necessary to accomplish their duties. So you will stand by another year and watch paint dry? Their communication and actions are a travesty and reek of incompetence. Calling it like it is. If you cannot see this you might look in the mirror before denigrating others."
Another Green Day ??
Cool……
$$ UEEC $$
You have a lot of numbers/percentages in that post. Did you take a poll?
You have a lot of numbers/percentages in that post. Did you take a poll? Send out fliers? Or, just made it up out of your ass, like all the other stuff you post.
UEEC—FOR THE WIN!!!
UEEC--Still a fan of me, I see.
Don't worry I have 6700+ of them on I-HUB.
How come you never see any of these 6700+ people enthused about this POS fraudulent Ponzi Scheme, buying into it, and posting on this board?
Answer: you PM them you will follow them if they follow you because you think it makes you look like an authority. Maybe to the United Health Fraud Ponzi Scheme operators who give you shares to bullshit suckers. But who else is fooled? Actually, you are quite useful to these followers. They see where you go and know what to stay away from because you never know what you are talking about. For instance, this POS fraudulent scam has gone down over 90% in less than 5 years while you rave about it. Go ahead and click on 5 yrs in the linked chart:
https://finance.yahoo.com/quote/UEEC
They follow you and distance themselves. The price action over the last 5 years, and lack of interest, speaks volumes about why you are followed. These followers know you as well as I do.
UEEC--Still a fan of me, I see.
Don't worry I have 6700+ of them on I-HUB.
Toodles.
fool
noun
a person who acts unwisely or imprudently; a silly person.
UEEC--Still a fan of me, I see.
Don't worry I have 6700+ of them on I-HUB.
Toodles.
In summation, I am fascinated by your continued references to me, I can tell you are a HUGE fan. Maybe when this is all over, I will hold one certificate share of UEEC stock, autograph it and mail it to you, to commemorate our stellar relationship. Given that I believe that UEEC stock will be somewhere between $5.00--$10.00 ++, and the cost of 1 forever postage stamp, this gift will cost me $5.75--$10.75, but you will need it
In reality, that is utterly none of your business.
Not to mention that you and everyone else is an anonymous alias with no true way of verifying a single thing one posts.
I own 231,334,722 shares going on three years of ueec. Prove me wrong.
"FIRST CLAIM FOR RELIEF
Violations of Exchange Act Section IO(b) and Rule 10b-5 Thereunder
(UHP and Beplate)
SECOND CLAIM FOR RELIEF
Violations of Exchange Act Section I0(b) and Rules IOb-S(a) and (c) Thereunder
(Schiliro)
THIRD CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section lO(b) and Rule 10b-5(b)
(Schiliro)
FOURTH CLAIM FOR RELIEF
Violations of Securities Act Section 17(a)
(All Defendants)
FIFTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a), 13(b)(2)(A) and 13(b)(2)(B)
of the Exchange Act and Rules 12b-20, 13a-1 and 13a-13 Thereunder
(UHP)
SIXTH CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section 13(a),
13(b)(2)(A), 13(b)2)B), and Rules 12b-20, 13a-1 and 13a-13
(Beplate and Schiliro)
SEVENTH CLAIM FOR RELIEF
Violation of Section 13(b)(5) of the Exchange Act and Exchange Act Rule 13b2-1
(Beplate and Schiliro)
EIGHTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a) and Rule 13a-14 Thereunder
(Beplate)
NINTH CLAIM FOR RELIEF
Violations of Rule 13b2-2 of the Exchange Act
(Beplate and Schiliro)
TENTH CLAIM FOR RELIEF
Violations of Sarbanes-Oxley Act Section 304(a)
(Beplate)
ELEVENTH CLAIM FOR RELIEF
Violations of Exchange Act Section 16(a) and Rule 16a-3 Thereunder
(Beplate)"
UEEC-another bald-face lie from 🖕Sporty🖕..."As you, yourself stated, "Do not be hindered by the truth, it gets in the way of bashing."", You aren't quoting me, You are just plain pathological in your fabrications. Obviously, you can't cite a post containing that. But hey, we can't expect anything else from you and your cronies involved in this sociopathic scam based on a fraudulent company with a hyped fictitious magic bandage..
Can’t disagree when someone is right
It's so much easier if you just stop writing to these low lives
UEEC--So predictable. Never addresses his purpose/agenda for his pointless vitriol and negatively biased mistruths. As you, yourself stated, "Do not be hindered by the truth, it gets in the way of bashing."
You will never reveal why you are here, and that is fine with me. When UEEC gets that approval, you will disappear into cyber oblivion, where you belong. Remember to pick another clever alias by which to obscure your true intentions.
Actually, you addressed me and I responded. But don't let that get in the way of your narrative. The truth never has and evidently never will. And it is more jaw dropping, amazed, utter bemusement at your lack of common sense and rejection of logic rather than being a fan in the conventional sense. By the way, have you forgotten all the "fan club" PM's I received from someone with a little doggie that wears a hat?
"No one has been ghosted by me."
"In summation, I am fascinated by your continued references to me, I can tell you are a HUGE fan. Maybe when this is all over, I will hold one certificate share of UEEC stock, autograph it and mail it to you, to commemorate our stellar relationship. Given that I believe that UEEC stock will be somewhere between $5.00--$10.00 ++, and the cost of 1 forever postage stamp, this gift will cost me $5.75--$10.75, but you will need it."
I've always maintained there is a long history of FDA submissions to the contrary of what you are stating. Check my posts. In fact, this bullshit has been going on since 2017. What is missing is a copy of the actual FDA determination and actual reasons for rejection. I wonder why United Health Fraud never divulges that?
"no FDA submissions"
""FDA Selects HemoStyp ® for CtQ Pilot Program
Henderson, Nevada – December 4, 2017 –United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it is proceeding with its application for HemoStyp under the FDA’s new and innovative CtQ Pilot Program. The FDA selected UHP’s HemoStyp as only one of nine participants for the program. UHP management has scheduled its first face-to-face meeting with FDA experts for January 17, 2018 to provide the agency with whatever information it needs to advance the application for premarket approval (PMA).
The FDA has stated that it intends to work collaboratively with pilot program participants during the review of their PMA submission to define characteristics of the device that are critical to product quality, and how these characteristics are controlled in design and manufacturing prior to the postmarket inspection. For pilot program participants, the FDA would forego conducting the standard PMA preapproval inspection, and a postmarket inspection focusing on the PMA applicant’s implementation of the critical to quality characteristics would be conducted instead.
The CtQ Pilot Program was created to identify products that have a chemical makeup of demonstrated safe interaction with the body –as evidenced by years of prior product usage and studies-- to be approved for Class III internal surgical use. The program’s intent is to allow products that have demonstrated repeated safe interaction to enter the market in a more efficient manner. This application will run simultaneously with the company’s prior Class II application for expanded indication. The market for 2017 internal surgical market for hemostatic products is estimated at in excess of seven billion dollars, and is expected to grow at 7.1% over the next few years, to reach more than $8.3 billion by 2022. (http://industryarc.com/Report/15189/hemostats-market.html)
Concurrent with its CtQ Pilot Program participation, UHP reaffirms that its current Class II application – Expanded Indication submission with the US FDA-- continues to progress, and is in an advanced stage of review
About Premarket Approval Application Critical to Quality (PMA CtQ) Pilot Program
Top-quality medical devices help the FDA better protect and promote public health. And one of the top priorities for FDA’s medical devices center is a focus on quality.
More specifically, the FDA is working with stakeholders—industry, health care providers, patients, payers, and investors—to build a strong Case for Quality.
This program allows the FDA to identify device manufacturers that consistently produce high-quality devices. By doing so, we can better focus our resources helping other manufacturers raise their level of quality. This program also helps the FDA identify and promote practices that support consistent quality manufacturing, and align our regulatory, enforcement, compliance approaches with those practices.
The FDA launched the Case for Quality in 2011 following an in-depth review of device quality data and feedback from both FDA and industry stakeholders. The FDA’s analysis flagged certain widespread or common manufacturing risks that impact product quality. The review also showed manufacturers that focus on and manage those risks often become more productive, receiving fewer complaints, needing to open fewer CAPAs and investigations, and having lower quality-related product costs than their competitors.
In simple terms, the review identified that an investment in quality has long-term payoffs."
See not ghosting anybody
UEEC--No one has been ghosted by me. Yet, you still refuse to answer any questions as to your reason for hanging out on a board that you have no equity investment in. I know, next Zorax will chime in saying nobody has to disclose anything, yada yada yada. What you and the other one fail to recognize is that anyone that would have put any credence at your combined prattle, is long gone. Those of us that remain are here, and nothing short of FDA communication is relevant. This includes your incessant assertions that there were no clinical studies, no FDA submissions, no peer reviews, again, yada yada yada. All myth. Your response to this will be links to nothing, hyperbole mixed with conjecture and statements of falsehoods presented as gospel. We have all heard it before.
In summation, I am fascinated by your continued references to me, I can tell you are a HUGE fan. Maybe when this is all over, I will hold one certificate share of UEEC stock, autograph it and mail it to you, to commemorate our stellar relationship. Given that I believe that UEEC stock will be somewhere between $5.00--$10.00 ++, and the cost of 1 forever postage stamp, this gift will cost me $5.75--$10.75, but you will need it.
And you said I’m being ghosted by him lol… what are we 15 years old??? You sure you’re old enough to have a brokerage account lol…
To think I always thought of Shangri-La as mythical.
Wow that’s a lot to grasp from me saying Sporty I can’t get you on private
.. you still avoided my question
and you really need to dedicate your time to something better
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |